Patient and public involvement No patients or members of the public participated in developing the hypothesis, specific aims, or research questions owing to a limited timeline for this project, neither were they involved in designing or implementing the study
Our study describes a novel action of GLP-1 signalling in -cells, which stimulates metabolic/bioenergetic reprograming resulting in a high glycolytic/high ATP generating phenotype, as detailed in (Fig
Important Notes Practical points that keep once-weekly administration consistent and reflect the honest limits of a combination that stacks two potent metabolic peptides
However, this flexibility also allows GSH to penetrate deeper into the binding pocket and reach the dicopper active site
These claims are being made about products that have no regulatory basis for them in Australia
For example, adding 1 mL of bacteriostatic water to a 5 mg/mL vial (already containing 1 mL of solution) produces 5 mg in 2 mL, or 2.5 mg/mL